XBiotech Inc.
XBIT
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, orā¦ read more
Healthcare
Biotechnology
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$3.15
Price-2.78%
-$0.09
1Y
Price
Market Cap
$96.036m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$0.00
-
1y CAGR-
3y CAGR-
5y CAGREarnings
-$39.413m
-
1y CAGR-
3y CAGR-
5y CAGREPS
-$1.29
-
1y CAGR-
3y CAGR-
5y CAGRBook Value
$174.713m
$181.864m
Assets$7.151m
Liabilities-
DebtDebt to Assets
0.00%
-
Debt to EBITDAFree Cash Flow
-$31.624m
-
1y CAGR-
3y CAGR-
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company